Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04115046 · ClinicalTrials.gov registry record
The EUS ShearWave Elastography Liver Fibrosis Study
A clinical trial, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- 52
- Enrollment target
NCT04115046 is a clinical trial that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 52 participants.
The verdict
NCT04115046 has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The study objective is to demonstrate the clinical performance of ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS) when compared to FibroScan for evaluation of liver fibrosis.
Interventions
- DEVICE FibroScan
- DEVICE ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS)
- DEVICE ALOKA ARIETTA 850 -
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2021-05-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04115046
The ClinicalTrials.gov registry entry for NCT04115046 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olympus Corporation of the Americas, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which FibroScan is the first listed.
NCT04115046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04115046 about?
NCT04115046 is a clinical study titled "The EUS ShearWave Elastography Liver Fibrosis Study". The study objective is to demonstrate the clinical performance of ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS) when compared to FibroScan for evaluation of liver fibrosis.
What is the current status of trial NCT04115046?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2020-07-14. Estimated completion is 2021-05-17.
What interventions are being tested in trial NCT04115046?
The interventions under investigation include: FibroScan (DEVICE), ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS) (DEVICE), ALOKA ARIETTA 850 - (DEVICE).
Who is sponsoring clinical trial NCT04115046?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.